These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 20674464)

  • 41. Bone morphogenetic protein signalling in pulmonary hypertension: advances and therapeutic implications.
    Yang K; Wang J; Lu W
    Exp Physiol; 2017 Sep; 102(9):1083-1089. PubMed ID: 28449240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TGF-beta signaling in vascular biology and dysfunction.
    Goumans MJ; Liu Z; ten Dijke P
    Cell Res; 2009 Jan; 19(1):116-27. PubMed ID: 19114994
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bone morphogenetic protein signaling in the developing kidney: present and future.
    Cain JE; Hartwig S; Bertram JF; Rosenblum ND
    Differentiation; 2008 Oct; 76(8):831-42. PubMed ID: 18331343
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bone morphogenetic proteins in the early development of zebrafish.
    Kondo M
    FEBS J; 2007 Jun; 274(12):2960-7. PubMed ID: 17521339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Signal transduction and biological functions of bone morphogenetic proteins.
    Chen D; Zhao M; Harris SE; Mi Z
    Front Biosci; 2004 Jan; 9():349-58. PubMed ID: 14766372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?
    Morrell NW
    Proc Am Thorac Soc; 2006 Nov; 3(8):680-6. PubMed ID: 17065373
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BMP signaling participates in late phase differentiation of the retina, partly via upregulation of Hey2.
    Kuribayashi H; Baba Y; Watanabe S
    Dev Neurobiol; 2014 Dec; 74(12):1172-83. PubMed ID: 24890415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways.
    Nohe A; Hassel S; Ehrlich M; Neubauer F; Sebald W; Henis YI; Knaus P
    J Biol Chem; 2002 Feb; 277(7):5330-8. PubMed ID: 11714695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells.
    Valdimarsdottir G; Goumans MJ; Rosendahl A; Brugman M; Itoh S; Lebrin F; Sideras P; ten Dijke P
    Circulation; 2002 Oct; 106(17):2263-70. PubMed ID: 12390958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone morphogenetic protein and blood vessels: new insights into endothelial cell junction regulation.
    Bautch VL
    Curr Opin Hematol; 2019 May; 26(3):154-160. PubMed ID: 30855335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extracellular regulation of BMP signaling: welcome to the matrix.
    Sedlmeier G; Sleeman JP
    Biochem Soc Trans; 2017 Feb; 45(1):173-181. PubMed ID: 28202671
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CRIM1 is necessary for coronary vascular endothelial cell development and homeostasis.
    Iyer S; Chhabra Y; Harvey TJ; Wang R; Chiu HS; Smith AG; Thomas WG; Pennisi DJ; Piper M
    J Mol Histol; 2017 Feb; 48(1):53-61. PubMed ID: 27803996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TAK1 mediates BMP signaling in cartilage.
    Greenblatt MB; Shim JH; Glimcher LH
    Ann N Y Acad Sci; 2010 Mar; 1192():385-90. PubMed ID: 20392264
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bone Morphogenetic Proteins and Diabetic Retinopathy.
    Elmasry K; Habib S; Moustafa M; Al-Shabrawey M
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33919531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The BMP Pathway in Blood Vessel and Lymphatic Vessel Biology.
    Ponomarev LC; Ksiazkiewicz J; Staring MW; Luttun A; Zwijsen A
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198654
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Robustness in angiogenesis: notch and BMP shaping waves.
    Beets K; Huylebroeck D; Moya IM; Umans L; Zwijsen A
    Trends Genet; 2013 Mar; 29(3):140-9. PubMed ID: 23279848
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting bone morphogenetic protein signaling on renal and vascular diseases.
    Maciel TT; Kempf H; Campos AH
    Curr Opin Nephrol Hypertens; 2010 Jan; 19(1):26-31. PubMed ID: 19823085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bone morphogenetic proteins, genetics and the pathophysiology of primary pulmonary hypertension.
    De Caestecker M; Meyrick B
    Respir Res; 2001; 2(4):193-7. PubMed ID: 11686884
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Defective pulmonary vascular remodeling in Smad8 mutant mice.
    Huang Z; Wang D; Ihida-Stansbury K; Jones PL; Martin JF
    Hum Mol Genet; 2009 Aug; 18(15):2791-801. PubMed ID: 19419974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DRAGON, a bone morphogenetic protein co-receptor.
    Samad TA; Rebbapragada A; Bell E; Zhang Y; Sidis Y; Jeong SJ; Campagna JA; Perusini S; Fabrizio DA; Schneyer AL; Lin HY; Brivanlou AH; Attisano L; Woolf CJ
    J Biol Chem; 2005 Apr; 280(14):14122-9. PubMed ID: 15671031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.